Curis Inc reports results for the quarter ended in September - Earnings Summary

Curis

02/11/2023 13:37

* Curis Inc  CRIS.OQ  reported a quarterly adjusted loss of
$2.13​​ per share for the quarter ended in September, higher
than the same quarter last year, when the company reported EPS
of $-2.80.  The mean expectation of five analysts for the
quarter was for a loss of $2.33 per share. Wall Street expected
results to range from $-2.80 to $-2.00 per share.
    * Revenue rose 0.3% to $2.83 million from a year ago;
analysts
expected $2.54 million. 
    * Curis Inc's reported EPS for the quarter was a loss of
$2.13​.
    * The company reported a quarterly loss of $12.18 million.
    * Curis Inc shares had fallen by 28.5% this quarter and
lost 57.2%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 3.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Curis Inc is
$80.00 
This summary was machine generated from LSEG data November 2 at
01:37 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -2.33          -2.13          Beat
 Jun. 30 2023      -2.36          -2.40          Missed
 Mar. 31 2023      -2.08          -2.40          Missed
 Dec. 31 2022      -2.60          -2.40          Beat